Immatics at Cell Therapy Manufacturing & Gene Therapy Congress (Dec 4-6) in Amsterdam, The Netherlands

| News, USA

Fast track cell, gene & CAR-T commercialization from concept to robust patient-centric delivery

Meet Immatics at the Cell Therapy Manufacturing & Gene Therapy Congress at the RAI in Amsterdam and discuss approaches to improve the way from the first concept to the final clinical program and commercialization of cell, gene and CAR-T research.

 

Tuesday, Dec 3, 2.30-3pm

Workshop 1 Afternoon Session: Clinical and Early Stage CAR T and Cell Therapy Advances – Allogeneic, Solid Tumors, Combination Therapies and Safety Switches

Off-the shelf, TCR-transduced γδ T cells for solid cancers

Presenter: Ali Mohamed, VP CMC Immatics US

 

Further information about 2019's Cell Therapy Manufacturing & Gene Therapy Congress here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.